How to Help a Senior Dog Regain Lost Energy Safely

By Meghan Jaskot, DVM

✓ Medically reviewed by Meghan Jaskot, DVM — August 31, 2026 For general education — not a substitute for veterinary care.

Longevity · September 4, 2026 · 6 min read

Before you reach for a supplement, rule out the treatable causes of fatigue — because "she's just getting old" is often wrong.

A 9-year-old Labrador mix stops meeting her owner at the door. She still eats fine, still wags, but the zoomies are gone and the walk that used to take twenty minutes now takes thirty-five because she keeps stopping. Her owner calls it “old age.” Three weeks later, bloodwork shows a thyroid panel flagged low-normal, and a repeat mobility exam turns up bilateral hip discomfort she’d been quietly compensating for. Nothing about that story is dramatic. It’s also the most common one I see, and it’s why “regain lost energy” is the wrong first question — the right one is “what changed, and when.”

Rule out the treatable before you treat the symptom

Energy loss in an older dog is a symptom, not a diagnosis, and treating it like the latter is the single most common mistake I see owners make. Hypothyroidism is one of the most frequently underdiagnosed causes — it’s among the most common hormonal diseases in dogs and typically shows up first as low-grade lethargy, weight gain, and hair changes years before anyone thinks to test for it, according to the Merck Veterinary Manual. Anemia, early heart disease, and pain are the other three usual suspects, and arthritis in particular gets missed constantly because owners — reasonably — assume stiffness and slowing down are just part of getting old. They’re often part of a specific, manageable condition instead.

This is the load-management lens Loadline applies to working and athletic dogs, and it holds just as well for a couch-based senior: fatigue is downstream of something. Before anyone reaches for a supplement, the job is to identify what’s actually limiting the dog’s tissue tolerance or metabolic output — not to paper over the symptom. The 2023 AAHA Senior Care Guidelines for Dogs and Cats recommend baseline screening bloodwork and a structured mobility exam as standard senior care, precisely because so many energy complaints trace back to something a physical exam alone won’t catch. If your dog is genuinely dragging — not just a little slower on stairs, but flat, uninterested in food, or panting at rest — that’s a same-week vet visit, not a wait-and-see.

What “regain energy” can and can’t mean

Here’s where I land, and where I diverge from a lot of senior-dog content: once medical causes are ruled out or treated, the realistic goal is slowing the decline and supporting what’s left — not restoring a 9-year-old dog to puppy output. That’s not pessimism, it’s physiology. Cellular energy production genuinely declines with age. NAD+ (nicotinamide adenine dinucleotide), a coenzyme every cell needs for energy metabolism, drops measurably as dogs get older, which is why NAD+ precursors and related compounds have become a serious research focus in canine aging rather than a fad ingredient.

The strongest data point I can point owners to is a randomized, controlled, double-blinded trial of a combined NAD+ precursor and senolytic in 70 dogs with mild to moderate cognitive impairment. The Scientific Reports trial found owner-assessed cognitive improvement in the treated groups over the study period — a real signal, and one of very few controlled canine trials in this space. It’s worth being precise about what it does and doesn’t show: it measured cognition, not raw energy or activity level, and it used a specific combination product, not any single ingredient in isolation. I’ll defend using this evidence to counsel owners on cognitive support. I won’t extend it into a promise about energy or lifespan, because the trial didn’t measure those things.

Quercetin, a flavonoid studied for antioxidant and cellular support properties, has shown effects on feeding behavior and stress response in lab models, though the mechanistic work so far is largely in simpler organisms rather than dogs — one recent study noted that quercetin, alongside NAC and ascorbic acid, “did not affect the feeding behavior” of the model organism at the concentrations tested (DOI.3390/ph19040525). Resveratrol research tells a similarly mixed story: one 2026 study found that embryonic exposure to a related compound “accelerated pupation and adult emergence but shortened adult lifespan” in an invertebrate model (DOI.1016/j.phymed.2026.158531) — a reminder that dose and life stage matter enormously, and that promising cellular mechanisms don’t automatically translate into a clean aging benefit. This is exactly the kind of nuance a sports-medicine desk insists on and a supplement aisle usually skips.

A owner survey circulated in early 2025 — not a controlled trial, but a real dataset — reported that among 193 respondents, 97.8% saw some visible improvement after the first month of use, with 94% noting cognitive changes and 98% noting energy changes. I mention it because it reflects genuine owner-perceived experience at scale, and honest reporting means naming its limits too: it’s uncontrolled, self-reported, and can’t isolate ingredient effect from placebo, routine change, or simple attention bias. Owner surveys and RCTs answer different questions, and conflating them is where a lot of supplement marketing goes wrong.

Where owners get this wrong, and what actually helps

A 62-pound retriever mix I think about often came in at age 11 after his owner tried three different “senior energy” chews over four months with no change she could point to. By day 10 on the third product she was ready to give up. What actually moved things wasn’t a fourth supplement — it was a same-week recheck that found a subclinical UTI and mild dehydration from a recent diet switch, both invisible on the surface. Energy came back within two weeks of treating the actual problem. The supplements weren’t wrong to try; they just weren’t the right first move, and no chew was ever going to fix an infection.

Sleep quality, consistent low-impact movement, and nutrition adequacy do more heavy lifting than most owners expect, and none of it requires a product. Short, frequent walks rather than one long outing reduce the boom-and-bust pattern that makes older joints and cardiovascular systems work harder than they need to. Weight management matters more with every added year — extra pounds on an arthritic hip cost the dog real function. None of this is training-load prescription; that call belongs to your vet or a canine rehabilitation specialist, especially if there’s any orthopedic diagnosis in play. For dogs whose slowdown started specifically around age 8 with no other red flags, some owners look into targeted NAD+ precursor support as one piece of a broader plan — worth understanding on its own terms rather than as a first-line fix.

The edge case that changes my advice: a 14-year-old dachshund, 19 pounds, whose owner described “low energy” that was actually reluctance to move because of new hind-limb weakness, not fatigue at all. Those look identical from the couch. They are not the same problem, and treating one like the other wastes real time. If a dog’s “tiredness” is really about not wanting to get up rather than lacking the drive to, that’s a neurologic and orthopedic triage question, not an energy-support one — and it’s worth ruling out before any supplement conversation starts. Cardiac causes deserve the same scrutiny; a subtle nutritional deficiency can also present first as exercise intolerance rather than anything owners would call “heart trouble.”

Where the evidence is thin, and what I tell owners

I’ll be honest about the limits here. Canine-specific research on NAD+ precursors is still sparse — one controlled cognitive trial and scattered mechanistic work is not the same evidentiary base as, say, decades of orthopedic NSAID data. The strongest counterargument to recommending these products is simply that we don’t yet have a large, energy-specific, dog-only RCT to point to. I still think targeted use is reasonable for the right dog, after medical causes are addressed, because the underlying cellular-energy mechanism is biologically plausible and the safety profile in the available data is favorable. That’s a bounded recommendation, not a blanket one.

What tends to help across the board: a same-day rule-out exam if the change is sudden, a slower and more forgiving exercise pattern if it’s gradual, and realistic expectations either way. A dog who used to run isn’t going to run the same way at 12. The goal is a dog who’s comfortable, interested, and moving well within what her body can actually do now — and behavior changes unrelated to fatigue, like new sound sensitivity, are worth mentioning to your vet in the same visit, since aging brains and aging bodies rarely decline on separate timelines.

In short: rule out the medical causes first, treat what’s treatable, and think of any supplement as support for a plan — not a replacement for one.